Magnetar Financial LLC Rvl Pharmaceuticals PLC Transaction History

Magnetar Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.26 - $4.84 $1.83 Million - $2.72 Million	-561,978 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.12 - $6.29 $558,873 - $853,232	135,649 Added 31.82%	561,978 $2.32 Million
Q3 2020 Nov 16, 2020	BUY	$4.82 - $8.77 $2.05 Million - $3.74 Million	426,329 New	426,329 $2.31 Million
Q2 2020 Aug 14, 2020	SELL	$2.83 - $6.99 $101,274 - $250,144	-35,786 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $113,799 - $250,502	35,786 New	35,786 $114,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.